Recent News

A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies

May 25, 2018

Purpose: The purpose of this study is to determine the safety, tolerability, and preliminary efficacy of INCAGN02385 in participants with advanced malignancies.

Olaparib in People With Malignant Mesothelioma

May 25, 2018

Purpose: The drug olaparib may stop cancer cells from fixing damage to their DNA. It has been approved to treat certain cancers in people that were born with a mutation in the BRCA gene. It has not been approved for treating mesothelioma. But some people with mesothelioma have mutations in a gene, BAP1 related to BRCA. Researchers want to see if olaparib can work in patients with mutations in this gene. They also want to see if works on mutations in other genes or patients without any mutations. They want to see if olaparib causes mesothelioma tumors to shrink.

Immunotherapy – What Side Effects Can You Expect?

May 22, 2018

As the success of immunotherapy treatments in improving survival and symptom management for cancer patients have started to become known, those suffering from cancer such as mesothelioma and lung cancer…

Techniques for Determining a Mesothelioma Diagnosis

May 21, 2018

If you have been exposed to asbestos and are exhibiting symptoms of mesothelioma including: pain in the side of your chest and lower back, shortness of breath, cough, fever, excessive…

A Global Study to Assess the Effects of Osimertinib Following Chemoradiation in Patients With Stage III Unresectable Non-small Cell Lung Cancer (LAURA)

May 16, 2018

Purpose: A global study to assess the efficacy and safety of osimertinib following chemoradiation in patients with stage III unresectable Epidermal Growth Factor Receptor Mutation Positive non-small cell lung cancer

ONCOS-102 Update: Mesothelioma Patients Responded after Phase II Clinical Trial

May 16, 2018

Advancement in mesothelioma treatments over the past decade has been relativity stagnant, according to Targovax  – a Norwegian immune-cology company dedicated to the study and research of immunotherapy treatments. However,…

Safer and Less Intrusive Lung Cancer Test

May 10, 2018

In order to test for cancer, people have to go through invasive and even risky procedures to remove and biopsy a tumor. With these risky procedures between 75 and 85…

Aerosol Chemotherapy – Targeting Peritoneal Mesothelioma Through Pressurized Medicine

May 3, 2018

Peritoneal mesothelioma is an incredibly rare form of cancer that affects the peritoneum, or abdominal lining. It is not entirely understood how exposure to asbestos causes this type of cancer,…

Phase II Nivolumab and Ramucirumab for Patients With Previously-Treated Mesothelioma

April 27, 2018

Purpose: This study will evaluate the combination of Nivolumab and Ramucirumab in patients with previously-treated mesothelioma.

New Surgical Technique Could Be Ideal for Patients with Advanced Pleural Mesothelioma

April 27, 2018

Pleural mesothelioma is a rare and aggressive cancer that has been notoriously difficult to treat. Caused by asbestos exposure, the latency period between the time of initial exposure and disease…